Abstract. In this study, we examined whether adiponectin suppresses endoplasmic reticulum (ER) stress in nonalcoholic steatohepatitis (NASH) using male transgenic mice expressing nSREBP-1c in adipose tissue, nSREBP-1c/adiponectin doubletransgenic mice expressing human adiponectin in the liver, and wild-type male mice as the control. Histological findings similar to those observed in liver specimens from patients with NASH were observed in the livers from the nSREBP-1c transgenic mice at 30 weeks of age. By contrast, the NASH-like liver histology was markedly attenuated in age-matched nSREBP-1c/adiponectin double-transgenic mice. The nSREBP-1c/adiponectin double-transgenic mice showed human adiponectin production in the liver and a restored circulating human adiponectin level. Human adiponectin messenger ribonucleic acid (mRNA) expression in the liver was identified in the nSREBP-1c/adiponectin double-transgenic mice, but adiponectin receptor 1 and 2 mRNA expression in the liver was normal. TNFα mRNA was decreased in the liver of the nSREBP-1c/adiponectin doubletransgenic mice compared with the nSREBP-1c transgenic mice. The protein expressions of X-box-binding protein-1, activating transcription factor 4, acetyl-CoA carboxylase, TNFα and NFÎșB were down-regulated in liver tissues from the nSREBP-1c/adiponectin double-transgenic mice. Mouse adiponectin and activating transcription factor 6 expressions were almost the same in the three groups. Post-load plasma glucose levels were significantly lower in the nSREBP-1c/adiponectin double-transgenic mice compared with the nSREBP-1c transgenic mice. These results indicate that adiponectin expressed in the liver suppresses ER stress and attenuates hepatic steatosis, inflammation and insulin resistance in NASH. Adiponectin may open the way to novel therapies for human NASH.
IntroductionThe liver plays a central role in whole-body lipid metabolism by governing the synthesis, oxidization, transport and excretion of lipids. Unfolded protein response (UPR) was identified as a signal transduction system that is activated by endoplasmic reticulum (ER) stress (1). ER stress and activation of UPR have been linked to numerous human disorders, including obesity, type 2 diabetes and cancer (2). In addition, Rutkowski et al showed that unresolved ER stress contributes to metabolic dysfunction and hepatic steatosis (3).UPR is a signaling system emanating from ER that is activated when ER protein folding is disturbed (4). Previous studies have revealed novel diverse functions of mammalian UPR, including its role in hepatic lipid metabolism (3). UPR activation has been observed in fatty liver diseases, suggesting the induction of ER stress in these conditions (5). Previous studies have demonstrated that ER stress activates the sterol regulatory element-binding proteins (SREBPs), transcription factors involved in de novo lipid biosynthesis (6). SREBPs play a significant role in cholesterol metabolism and LDL receptor expression (SREBP-2), as well as fatty acid and triglyceride biosynthes...